Related Experiment Video
Updated: Dec 15, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.8K
Long-term course and morphological MRI correlates of cognitive function in multiple sclerosis
Daniela Pinter1, Michael Khalil2, Lukas Pirpamer2
1Research Unit for Neuronal Plasticity and Repair, Medical University of Graz, Graz, Austria/Department of Neurology, Medical University of Graz, Graz, Austria.
Summary
Thalamic volume on MRI scans can predict long-term cognitive function in patients with multiple sclerosis (MS). Lower baseline thalamic volume identified individuals at higher risk for cognitive decline over a decade.
Area of Science:
- Neuroimaging
- Neurology
- Cognitive Science
Background:
- Cognitive impairment is common in multiple sclerosis (MS).
- Magnetic resonance imaging (MRI) may identify MS patients at risk for cognitive decline.
- Understanding the long-term trajectory of cognitive function in MS is crucial.
Purpose of the Study:
- To investigate the long-term course of cognitive function in MS patients.
- To identify morphological MRI correlates of cognitive changes over time.
- To assess the predictive value of baseline MRI markers for future cognitive decline.
Main Methods:
- 116 MS patients underwent baseline (BL) clinical, cognitive, and MRI assessments (2006-2012).
- Follow-up (FU) assessments occurred between 2016-2018, including disability (EDSS), cognition (BRB-N), T2-lesion load (T2-LL), brain volumes, and cortical thickness.
- 63 patients completed FU, with no significant differences from non-participants.
Main Results:
- No significant changes in disability or cognition were observed across the group over 10 years.
- Baseline thalamic volume, age, and baseline cognition predicted 67% of FU cognitive function variance.
- Cognitive decliners (23.8%) were older, had longer disease duration, and tended to have lower BL thalamic volume.
Conclusions:
- Baseline thalamic volume is a significant predictor of long-term cognitive function in MS patients.
- Thalamic volume can differentiate between MS patients with stable versus declining cognition.
- MRI markers, particularly thalamic volume, hold potential for identifying MS patients at risk for cognitive decline.

